"Direct-acting antivirals for hepatitis C: What should we expect?”
When |
Nov 12, 2010
from 08:30 AM to 09:30 AM |
---|---|
Where | 1131 Bioinformatics |
Contact Name | Kathy James |
Contact Phone | (919) 966-2536 |
Add event to calendar |
![]() ![]() |
The Center for Infectious Diseases and the Institute for Global Health and Infectious Diseases co-sponsor a weekly conference series featuring distinguished clinicians and scientists from UNC, local universities and other national and international institutions. The topics are varied and appeal to not only infectious disease specialists, but also professionals in epidemiology, public health, microbiology, biostatistics and other global health-related disciplines.
Dr. Lemon is a professor of medicine at UNC-CH. His laboratory is interested in the innate immune responses to RNA viruses, and how these viruses have evolved to escape these host defenses. Their research focuses on the molecular pathogenesis of hepatitis C virus (HCV) - related liver diseases, including in particular HCV-associated hepatocellular carcinoma, and the development of effective therapies for hepatitis C.